{"id":"https://openalex.org/W2783175942","doi":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","title":"Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study","display_name":"Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W2783175942","doi":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","mag":"2783175942"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v130.suppl_1.725.725","doi":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017435311","display_name":"St\u00e9phane de Botton","orcid":"https://orcid.org/0000-0002-8126-4942","observed_orcids":["https://orcid.org/0000-0002-8126-4942"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Stephane De Botton","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066934816","display_name":"Eytan M. Stein","orcid":"https://orcid.org/0000-0001-8992-9390","observed_orcids":["https://orcid.org/0000-0001-8992-9390"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eytan M. Stein","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail J. Roboz","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023917898","display_name":"Alice S. Mims","orcid":"https://orcid.org/0000-0002-8971-2199","observed_orcids":["https://orcid.org/0000-0002-8971-2199"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice S. Mims","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","Ohio State University Wexner Medical Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Ohio State University Wexner Medical Center, Columbus, OH","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032549755","display_name":"Daniel Aaron Pollyea","orcid":"https://orcid.org/0000-0001-6519-4860","observed_orcids":["https://orcid.org/0000-0001-6519-4860"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Pollyea","raw_affiliation_strings":["Division of Hematology, University of Colorado Denver, Aurora, CO","University of Colorado Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Colorado Denver, Aurora, CO","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032988049","display_name":"Ronan T. Swords","orcid":"https://orcid.org/0000-0003-3319-1870","observed_orcids":["https://orcid.org/0000-0003-3319-1870"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronan T. Swords","raw_affiliation_strings":["Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025780450","display_name":"Jessica Kaplan Altman","orcid":"https://orcid.org/0000-0003-1987-1896","observed_orcids":["https://orcid.org/0000-0003-1987-1896"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica K. Altman","raw_affiliation_strings":["Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089074892","display_name":"Robert H. Collins","orcid":"https://orcid.org/0000-0003-0313-2394","observed_orcids":["https://orcid.org/0000-0003-0313-2394"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert H. Collins","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085672843","display_name":"Gabriel N. Mannis","orcid":"https://orcid.org/0009-0000-8202-0870","observed_orcids":["https://orcid.org/0009-0000-8202-0870"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel N. Mannis","raw_affiliation_strings":["UCSF School of Medicine, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF School of Medicine, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101423957","display_name":"Geoffrey L. Uy","orcid":"https://orcid.org/0000-0002-7809-0996","observed_orcids":["https://orcid.org/0000-0002-7809-0996"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey L. Uy","raw_affiliation_strings":["Washington University School of Medicine, St Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046198086","display_name":"Will Donnellan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Will Donnellan","raw_affiliation_strings":["Sarah Cannon Research Institute, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003572390","display_name":"Arnaud Pigneux","orcid":"https://orcid.org/0000-0001-5479-0261","observed_orcids":["https://orcid.org/0000-0001-5479-0261"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Arnaud Pigneux","raw_affiliation_strings":["Clinical Hematology, Bordeaux University Hospital, Pessac, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology, Bordeaux University Hospital, Pessac, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010057352","display_name":"Amir Tahmasb Fathi","orcid":"https://orcid.org/0000-0003-4907-6447","observed_orcids":["https://orcid.org/0000-0003-4907-6447"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir T. Fathi","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061495135","display_name":"Anthony Selwyn Stein","orcid":"https://orcid.org/0000-0002-1786-1398","observed_orcids":["https://orcid.org/0000-0002-1786-1398"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony S. Stein","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050556099","display_name":"Harry Paul Erba","orcid":"https://orcid.org/0000-0003-1093-2189","observed_orcids":["https://orcid.org/0000-0003-1093-2189"]},"institutions":[{"id":"https://openalex.org/I17301866","display_name":"University of Alabama","ror":"https://ror.org/03xrrjk67","country_code":"US","type":"education","lineage":["https://openalex.org/I17301866"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry P. Erba","raw_affiliation_strings":["University of Alabama School of Medicine, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama School of Medicine, Birmingham, AL","institution_ids":["https://openalex.org/I17301866","https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069675791","display_name":"Gabrielle T. Prince","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gabrielle T. Prince","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035051206","display_name":"James M. Foran","orcid":"https://orcid.org/0000-0003-1673-1708","observed_orcids":["https://orcid.org/0000-0003-1673-1708"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Foran","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005105433","display_name":"Elie A. Traer","orcid":"https://orcid.org/0000-0001-8844-2345","observed_orcids":["https://orcid.org/0000-0001-8844-2345"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elie Traer","raw_affiliation_strings":["OHSU Knight Cancer Institute, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OHSU Knight Cancer Institute, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015493242","display_name":"Robert Kenneth Stuart","orcid":"https://orcid.org/0000-0001-7549-8008","observed_orcids":["https://orcid.org/0000-0001-7549-8008"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]},{"id":"https://openalex.org/I4210095449","display_name":"MUSC Hollings Cancer Center","ror":"https://ror.org/00w52vt71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert K. Stuart","raw_affiliation_strings":["Hollings Cancer Center, Medical University of South Carolina, Charleston, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hollings Cancer Center, Medical University of South Carolina, Charleston, SC","institution_ids":["https://openalex.org/I153297377","https://openalex.org/I4210095449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014892222","display_name":"Martha Lucia Arellano","orcid":"https://orcid.org/0000-0003-1636-1962","observed_orcids":["https://orcid.org/0000-0003-1636-1962"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha L. Arellano","raw_affiliation_strings":["Emory University School of Medicine, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University School of Medicine, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111427915","display_name":"James L. Slack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]},{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James L. Slack","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ","institution_ids":["https://openalex.org/I4210125099","https://openalex.org/I4210127938","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053897548","display_name":"Katharine E. Yen","orcid":"https://orcid.org/0000-0003-2054-9108","observed_orcids":["https://orcid.org/0000-0003-2054-9108"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katharine Yen","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009684277","display_name":"Stephanie M. Kapsalis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephanie M. Kapsalis","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100321336","display_name":"Hua Liu","orcid":"https://orcid.org/0000-0003-2798-3337","observed_orcids":["https://orcid.org/0000-0003-2798-3337","https://orcid.org/0009-0007-8715-2988"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hua Liu","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039774247","display_name":"Meredith A. Goldwasser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Meredith Goldwasser","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063673381","display_name":"Sam Agresta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sam Agresta","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089274301","display_name":"Eyal C. Attar","orcid":"https://orcid.org/0000-0002-1959-8079","observed_orcids":["https://orcid.org/0000-0002-1959-8079"]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eyal C. Attar","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001124933","display_name":"Martin S. Tallman","orcid":"https://orcid.org/0000-0002-4367-6102","observed_orcids":["https://orcid.org/0000-0002-4367-6102"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin S. Tallman","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":34,"corresponding_author_ids":["https://openalex.org/A5003572390","https://openalex.org/A5009684277","https://openalex.org/A5017435311","https://openalex.org/A5039774247","https://openalex.org/A5046198086","https://openalex.org/A5053897548","https://openalex.org/A5063673381","https://openalex.org/A5069675791","https://openalex.org/A5100321336","https://openalex.org/A5111427915"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2801843802","https://openalex.org/I3018323443","https://openalex.org/I4210092565","https://openalex.org/I4210100810","https://openalex.org/I4210125099","https://openalex.org/I4210127938","https://openalex.org/I4210164401","https://openalex.org/I4390039332"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"130","issue":"Suppl_1","first_page":"725","last_page":"725"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ivosidenib","display_name":"ivosidenib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.9670000076293945},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8629999756813049},{"id":"https://openalex.org/keywords/advanced-hematologic-malignancies","display_name":"advanced hematologic malignancies","score":0.8420000076293945},{"id":"https://openalex.org/keywords/2-hydroxyglutarate","display_name":"2-hydroxyglutarate","score":0.9120000004768372},{"id":"https://openalex.org/keywords/idh1-inhibitor","display_name":"IDH1 inhibitor","score":0.6819999814033508},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.628000020980835},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8629999756813049},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7360000014305115},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.5867998600006104},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.5552920699119568},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5106576085090637},{"id":"https://openalex.org/C2909984355","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic malignancy","level":2,"score":0.5102472305297852},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.4924353063106537},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39602938294410706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37709367275238037},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3728151321411133},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.3464648723602295},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2484111189842224},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16341963410377502},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08458739519119263},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07206413149833679}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v130.suppl_1.725.725","doi":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v130.suppl_1.725.725","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388290299","https://openalex.org/W2992705738","https://openalex.org/W4239134909","https://openalex.org/W4226248843","https://openalex.org/W3043200968","https://openalex.org/W2216448045","https://openalex.org/W2051661648","https://openalex.org/W2566537949","https://openalex.org/W2023978860","https://openalex.org/W3216083016"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Recurrent":[2],"isocitrate":[3],"dehydrogenase":[4],"(IDH)":[5],"1":[6,80,121,194,199,221,315,551],"mutations":[7],"are":[8,201,234],"observed":[9,463],"in":[10,84,137,166,187,347,351,413,464,474,484,591,596,641],"6-10%":[11],"of":[12,27,41,48,55,66,82,101,111,135,223,291,303,358,363,374,406,410,415,447,466,491,514,602,613,677,817,893,907,924,942,954,966,996,1018,1032,1045,1065,1080,1092,1104,1116,1128,1140,1203,1233],"patients":[13,42,85,113,151,200,229,273,322,345,366,385,416,486,554,642,686],"with":[14,43,86,108,203,355,526,643,660,687],"acute":[15],"myeloid":[16],"leukemia":[17],"(AML).":[18],"Ivosidenib":[19,636],"(AG-120),":[20],"a":[21,34,109,155,652],"potent,":[22],"selective,":[23],"oral,":[24,682],"small-molecule":[25],"inhibitor":[26],"the":[28,39,52,56,77,98,104,124,181,280,299,311,324,399,508,512,576,580,675],"mutant":[29],"IDH1":[30],"(mIDH1)":[31],"protein,":[32],"is":[33,97,507,638],"promising":[35],"therapeutic":[36],"candidate":[37],"for":[38,237,261,269,310,319,504,685],"treatment":[40,387,496,684],"mIDH1":[44,87,138,644,688],"AML.":[45,689],"Through":[46],"inhibition":[47],"mIDH1,":[49],"ivosidenib":[50,83,136,153,292,377,556,664,678],"suppresses":[51],"abnormal":[53],"production":[54],"oncometabolite":[57],"2-hydroxyglutarate":[58],"(2-HG),":[59],"leading":[60],"to":[61,184,212,298,376,388,390,457,482,494,519,575,994,1016,1030,1043,1063,1078,1090,1102,1114,1126,1138],"clinical":[62,133],"responses":[63],"via":[64],"differentiation":[65],"malignant":[67],"cells.":[68],"AIM:":[69],"To":[70],"report":[71,100],"safety":[72,256],"and":[73,132,174,195,226,244,283,330,441,453,488,541,563,594,611,646,668,1148],"efficacy":[74,502],"data":[75,102,257,318],"from":[76,103,323],"first-in-human":[78],"phase":[79,120],"study":[81,122,477],"advanced":[88,246,332,648],"hematologic":[89,139,247,333,528,649],"malignancies":[90,248,334],"including":[91,249,335,470,589],"relapsed/refractory":[92],"(R/R)":[93],"AML":[94,192,232,241,272,329,506,553,645,657],"(NCT02074839).":[95],"This":[96],"first":[99,289,568],"4":[105,188,228],"expansion":[106,189,284,326,564],"cohorts,":[107],"total":[110],"258":[112,344,364,467],"treated":[114,274,321,354],"on":[115,144,369,813,889,903,920,938,950,962,1199,1229],"study.":[116],"METHODS:":[117],"The":[118,169,371,445,500,622],"ongoing":[119],"assesses":[123],"safety,":[125],"maximum":[126],"tolerated":[127,640],"dose":[128,149,183,281,290,348,561,569],"(MTD),":[129],"pharmacokinetics,":[130],"pharmacodynamics,":[131],"activity":[134],"malignancies.":[140,650],"Enrollment":[141],"was":[142,171,178,378,396,462,479,583,604,615,627],"completed":[143],"May":[145,304,359],"8,":[146],"2017.":[147],"During":[148],"escalation,":[150,349],"received":[152,287,566],"as":[154,180,307,309,455,531,679],"single":[156],"agent":[157],"orally":[158],"once":[159],"daily":[160,164],"(QD)":[161],"or":[162,208,215,218,498,819,895,909,926,944,956,968,1205,1235],"twice":[163],"(BID)":[165],"28-day":[167],"cycles.":[168],"MTD":[170],"not":[172,235],"reached":[173],"500":[175,276,557],"mg":[176,277,558],"QD":[177,278,559],"selected":[179],"recommended":[182],"be":[185,259,267,339],"tested":[186],"cohorts:":[190],"R/R":[191,231,271,505,552,656],"(Arms":[193],"4,":[196],"where":[197],"Arm":[198,227,238,314,550],"those":[202],"relapse":[204,219],"after":[205],"transplantation,":[206],"second":[207],"later":[209],"relapse,":[210],"resistance":[211],"initial":[213,224],"induction":[214],"reinduction":[216],"treatment,":[217,225],"within":[220],"year":[222],"have":[230],"but":[233],"eligible":[236],"1);":[239],"untreated":[240],"(Arm":[242,253],"2);":[243],"other":[245,325,331,647],"myelodysplastic":[250],"syndrome":[251,460],"(MDS)":[252],"3).":[254],"Updated":[255],"will":[258,266,337],"presented":[260,268],"all":[262,270,320,990,1012,1026,1039,1059,1074,1086,1098,1110,1122,1134],"patients.":[263,599],"Efficacy":[264,317],"outcomes":[265],"at":[275,293,570],"across":[279,560],"escalation":[282,562],"cohorts":[285,327],"who":[286,565],"their":[288,567],"least":[294,571],"6":[295,572],"months":[296,380,573,606,617],"prior":[297,574],"analysis":[300,577],"cut-off":[301],"date":[302],"12,":[305,360],"2017,":[306,361],"well":[308,397,639],"poorest":[312],"prognosis":[313],"subset.":[316],"(untreated":[328],"MDS)":[336],"also":[338],"presented.":[340],"RESULTS:":[341],"In":[342,651],"all,":[343],"(78":[346],"180":[350],"expansion)":[352],"were":[353,367,417,450],"ivosidenib.":[356],"As":[357],"62":[362],"(24%)":[365],"continuing":[368],"treatment.":[370,458],"median":[372],"duration":[373,601,612],"exposure":[375],"3.5":[379],"(range":[381],"0.1-33.5).":[382],"Twenty-two":[383],"(8.5%)":[384],"discontinued":[386],"proceed":[389],"allogeneic":[391],"stem":[392],"cell":[393],"transplantation.":[394],"Treatment":[395],"tolerated;":[398],"most":[400],"common":[401],"adverse":[402],"events":[403],"(AEs)":[404],"(n=258)":[405],"any":[407],"grade":[408,471],"irrespective":[409],"causality":[411],"occurring":[412],"\u226520%":[414],"diarrhea":[418],"(33%),":[419],"leukocytosis":[420],"(30%),":[421,423],"nausea":[422],"fatigue":[424],"(29%),":[425],"febrile":[426],"neutropenia":[427],"(25%),":[428],"dyspnea":[429],"(24%),":[430],"anemia":[431],"(23%),":[432,435],"QT":[433],"prolongation":[434],"peripheral":[436],"edema":[437],"(22%),":[438],"pyrexia":[439],"(21%),":[440],"decreased":[442],"appetite":[443],"(20%).":[444],"majority":[446],"these":[448],"AEs":[449],"grades":[451],"1-2":[452],"reported":[454],"unrelated":[456],"Differentiation":[459],"(DS)":[461],"29":[465],"(11.2%)":[468],"patients,":[469],"\u22653":[472],"DS":[473,483,492],"14":[475],"(5.4%);":[476],"drug":[478],"held":[480],"owing":[481],"11":[485,597],"(4.3%),":[487],"no":[489],"instances":[490],"led":[493],"permanent":[495],"discontinuation":[497],"death.":[499],"primary":[501],"endpoint":[503],"CR+CRh":[509,581,603],"rate,":[510],"i.e.,":[511],"rate":[513,582,625],"complete":[515],"remission":[516],"(CR":[517],"according":[518],"modified":[520],"IWG":[521],"2003":[522],"criteria":[523],"plus":[524],"CR":[525,532,590,614],"partial":[527],"recovery,":[529],"defined":[530,655],"except":[533],"absolute":[534],"neutrophil":[535],"count":[536,543],">0.5":[537],"\u00d7":[538,545],"109/L":[539,546],"[500/\u00b5L]":[540],"platelet":[542],">50":[544],"[50,000/\u00b5L]).":[547],"Among":[548],"125":[549],"receiving":[555],"cutoff":[578],"date,":[579],"30.4%":[584],"(95%":[585,607,618,629],"CI":[586,608,619,630],"22.5%,":[587],"39.3%),":[588],"27":[592],"(21.6%)":[593],"CRh":[595],"(8.8%)":[598],"Median":[600],"8.2":[605],"5.5,":[609],"12.0),":[610],"9.3":[616],"5.6,":[620],"18.3).":[621],"overall":[623],"response":[624],"(CR+CRi/CRp+PR+MLFS)":[626],"41.6%":[628],"32.9%,":[631],"50.8%)":[632],"(52/125":[633],"patients).":[634],"CONCLUSION:":[635],"monotherapy":[637],"high-risk,":[653],"molecularly":[654],"patient":[658,670],"population":[659],"unmet":[661],"medical":[662],"need,":[663],"induced":[665],"durable":[666],"remissions":[667],"improved":[669],"outcomes.":[671],"These":[672],"findings":[673],"support":[674,992,1014,1028,1041,1061,1076,1088,1100,1112,1124,1136],"role":[676],"an":[680,814,890,904,921,939,951,963,1164,1200,1230],"effective,":[681],"targeted":[683],"Disclosures":[690],"DiNardo:":[691],"Celgene:":[692,718,835,916,979,1227,1275],"Honoraria,":[693,697,701,705,709,723,901,918,936,1180,1197],"Research":[694,698,702,706,710,724,731,735,739,745,753,762,796,824,853,856,859,862,868,871,912,929,932,1020,1034,1047,1067,1082,1094,1106,1118,1130,1142,1167,1173,1176,1184,1187,1190,1193,1210,1213,1216,1219,1224],"Funding;":[695,699,703,707,732,736,740,746,754,854,857,860,869,872,913,930,933,1021,1035,1048,1068,1083,1095,1107,1119,1131,1143,1168,1174,1177,1185,1188,1191,1194,1211,1214,1217],"AbbVie:":[696],"Agios:":[700,722,855,870,934,1084,1172,1239,1244,1256,1268,1294],"Daiichi-Sankyo:":[704],"Novartis:":[708,716,760,799,844,878,1005,1189,1273],"Funding.":[711,725,763,797,825,863,1220,1225],"De":[712],"Botton:":[713],"Pfizer:":[714,755,823,914,1053,1288],"Honoraria;":[715,717,719,721,866,915,1171],"Servier:":[720],"Stein:":[726,971],"GSK:":[727],"Other:":[728,750,757,830,847,880,981,1011,1025,1038,1058,1073,1085,1097,1109,1121,1133,1145,1181],"Advisory":[729],"Board,":[730],"Constellation":[733],"Pharma:":[734],"Seattle":[737,898,1055,1208],"Genetics:":[738,899,1056,1209],"Agios":[741,1249,1261],"Pharmaceuticals,":[742,782,784,1250,1262],"Inc.:":[743,1251,1263],"Consultancy,":[744,749,756,761,879,900,917,935,948,960,973,980,998,1002,1006,1010,1024,1037,1057,1072,1170,1179,1196],"Celgene":[747,851],"Corporation:":[748,852],"Travel":[751,758,881,1182],"expenses,":[752],"expenses;":[759],"Roboz:":[764],"AbbVie,":[765],"Agios,":[766,822],"Amgen,":[767],"Amphivena,":[768],"Array":[769],"Biopharma":[770],"Inc.,":[771],"Astex,":[772],"AstraZeneca,":[773],"Celator,":[774],"Celgene,":[775,805],"Clovis":[776],"Oncology,":[777],"CTI":[778],"BioPharma,":[779],"Genoptix,":[780],"Immune":[781],"Janssen":[783,841],"Juno,":[785],"MedImmune,":[786],"MEI":[787],"Pharma,":[788],"Novartis,":[789],"Onconova,":[790],"Pfizer,":[791,806],"Roche":[792],"Pharmace:":[793],"Consultancy;":[794,828,834,836,838,840,843,845,877,1050,1052,1054,1070,1154,1156,1274,1276,1278,1280,1283,1285,1287,1289,1291,1293,1295],"Cellectis:":[795],"Mims:":[798],"Honoraria.":[800,874],"Pollyea:":[801],"Takeda,":[802],"Ariad,":[803],"Alexion,":[804],"Pharmacyclics,":[807],"Gilead,":[808],"Jazz,":[809],"Servier,":[810],"Curis:":[811,865],"Membership":[812,888,902,919,937,949,961,1198,1228],"entity's":[815,891,905,922,940,952,964,1201,1231],"Board":[816,892,906,923,941,953,965,1202,1232],"Directors":[818,894,908,925,943,955,967,1204,1234],"advisory":[820,896,910,927,945,957,969,1206,1236],"committees;":[821,897,946,958,1207],"Altman:":[826],"Syros:":[827],"NCCN:":[829],"Educational":[831,848],"speaker;":[832],"BMS:":[833,861],"Astellas:":[837,1108,1218,1286],"Ceplene:":[839],"Pharmaceuticals:":[842],"ASH:":[846],"speaker.":[849],"Collins:":[850],"Arog:":[858,1290],"Mannis:":[864],"Juno:":[867,887,1096],"Amgen:":[873,959,972,1009,1169,1277],"Uy:":[875],"GlycoMimetics:":[876],"Suppport;":[882],"Boehringer":[883],"Ingelheim:":[884],"Consultancy.":[885,977,1297],"Fathi:":[886],"committees,":[911,928],"Takeda:":[931],"Medimmune:":[947],"committees.":[970,1237],"Speakers":[974,987,999,1003,1007],"Bureau;":[975,988,1000,1004,1008],"Stemline:":[976],"Erba:":[978],"Chair,":[982,1146],"Scientific":[983],"Steering":[984],"Committee":[985],",":[986],"Incyte:":[989,1192],"research":[991,1013,1027,1040,1060,1075,1087,1099,1111,1123,1135],"paid":[993,1015,1029,1042,1062,1077,1089,1101,1113,1125,1137],"University":[995,1017,1031,1044,1064,1079,1091,1103,1115,1127,1139],"Alabama,":[997,1019,1033,1046,1066,1081,1093,1105,1117,1129,1141],"Jazz:":[1001,1284],"Daiichi":[1022],"Sankyo:":[1023],"ImmunoGen:":[1036,1153],"MacroGen:":[1049],"Ono:":[1051,1292],"Sunesis:":[1069,1178],"Millennium/Takeda:":[1071],"Celator:":[1120],"Janssen:":[1132],"Glycomimetics:":[1144],"Data":[1147],"Safety":[1149],"Monitoring":[1150],"Committee.":[1151],"Traer:":[1152],"Tolero:":[1155],"Notable":[1157],"Labs:":[1158],"Equity":[1159,1241,1246,1253,1258,1265,1270],"Ownership.":[1160,1242,1247,1254,1259,1266,1271],"Stuart:":[1161],"Pharmacyclics":[1162],"LLC,":[1163],"AbbVie":[1165],"Company:":[1166],"Celator/Jazz:":[1175],"Support,":[1183],"Bayer:":[1186],"ONO:":[1195],"MedImmune:":[1212],"Cantex:":[1215],"Arellano:":[1221],"Cephalon":[1222],"Oncology:":[1223],"Sekeres:":[1226],"Yen:":[1238],"Employment,":[1240,1245,1252,1257,1264,1269],"Kapsalis:":[1243],"Liu:":[1248],"Goldwasser:":[1255],"Agresta:":[1260],"Attar:":[1267],"Stone:":[1272],"Abbvie:":[1279],"Fuji":[1281],"Film:":[1282],"Sumitomo:":[1296],"Kan":[1298]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}